Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1985 1
1995 1
1999 1
2000 15
2001 11
2002 13
2003 10
2004 16
2005 11
2006 6
2007 14
2008 16
2009 20
2010 16
2011 15
2012 18
2013 18
2014 13
2015 18
2016 15
2017 10
2018 10
2019 6
2020 10
2021 4
2022 3
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

265 results

Results by year

Filters applied: . Clear all
Page 1
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Gokmen E, Bashford A, Ruiz Borrego M, Kim SB, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A; ExteNET Study Group. Martin M, et al. Lancet Oncol. 2017 Dec;18(12):1688-1700. doi: 10.1016/S1470-2045(17)30717-9. Epub 2017 Nov 13. Lancet Oncol. 2017. PMID: 29146401 Clinical Trial.
Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma.
Choueiri TK, Escudier B, Powles T, Mainwaring PN, Rini BI, Donskov F, Hammers H, Hutson TE, Lee JL, Peltola K, Roth BJ, Bjarnason GA, Géczi L, Keam B, Maroto P, Heng DY, Schmidinger M, Kantoff PW, Borgman-Hagey A, Hessel C, Scheffold C, Schwab GM, Tannir NM, Motzer RJ; METEOR Investigators. Choueiri TK, et al. N Engl J Med. 2015 Nov 5;373(19):1814-23. doi: 10.1056/NEJMoa1510016. Epub 2015 Sep 25. N Engl J Med. 2015. PMID: 26406150 Free PMC article. Clinical Trial.
A hundred years after the first article, a recollection: Cabot ring.
Erdem N, Berber İ, Aydoğdu İ, Sevinç A. Erdem N, et al. Among authors: sevinc a. Korean J Intern Med. 2016 Jan;31(1):199. doi: 10.3904/kjim.2016.31.1.199. Epub 2015 Dec 28. Korean J Intern Med. 2016. PMID: 26767879 Free PMC article. No abstract available.
Renal cell cancer: overview of the current therapeutic landscape.
Erman M, Benekli M, Basaran M, Bavbek S, Buyukberber S, Coskun U, Demir G, Karabulut B, Oksuzoglu B, Ozkan M, Sevinc A, Yalcin S. Erman M, et al. Among authors: sevinc a. Expert Rev Anticancer Ther. 2016 Sep;16(9):955-68. doi: 10.1080/14737140.2016.1222908. Epub 2016 Aug 24. Expert Rev Anticancer Ther. 2016. PMID: 27548347 Review.
A national, multicenter, non-interventional, observational study on treatment patterns in patients with metastatic renal cell carcinoma in Turkey - NOTES study.
Yalçın Ş, Yildiz R, Dane F, Karaoğlu A, Öksüzoğlu B, Özyılkan Ö, Sevinç A, Özdemir F, Turna H, Uslu R, Ulay E. Yalçın Ş, et al. Among authors: sevinc a. Onco Targets Ther. 2018 Mar 5;11:1223-1228. doi: 10.2147/OTT.S148917. eCollection 2018. Onco Targets Ther. 2018. PMID: 29551901 Free PMC article.
265 results